Identification of novel beta3-adrenoceptor agonists using energetic analysis, structure based pharmacophores and virtual screening.
beta3 Adrenergic receptor (beta3-AR), is a potential therapeutic target for the treatment of type II diabetes and obesity. We report the identification of novel compounds as beta3-AR agonists by integrating different approaches of energetic analysis, stru.....